Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation

被引:113
作者
Nadiminty, Nagalakshmi
Lou, Wei
Lee, Soo Ok
Lin, Xin
Trump, Donald L.
Gao, Allen C.
机构
[1] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Dept Med, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Dept Pharmacol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Dept Therapeut, Buffalo, NY 14263 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Mol Oncol, Houston, TX 77030 USA
关键词
apoptosis; cancer; cell signal; prostate;
D O I
10.1073/pnas.0509808103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Activation of the noncanonical NF-kappa B signaling pathway involved in the proteolytic processing of NF-kappa B p100 to p52 is tightly regulated, and overproduction of p52 leads to lymphocyte hyperplasia and transformation. We have demonstrated that active but not latent Stat3, expressed in many types of human cancers involved in cell proliferation and survival, induces p100 processing to p52 by activation of IKK alpha and subsequent phosphorylation of p100. The Stat3-mediated p100 processing to p52 requires activation of Stat3 by the acetyltransferase activity of cAMP-response element-binding protein (CREB)-binding protein (CBP)/p300. A mutant of Stat3 defective in acetylation blocked Stat3-mediated p100 processing to p52 and acted as a dominant negative in blocking the production of p52. Furthermore, overexpression of p52 protected cells from apoptotic cell death. Thus, activation of the processing of p100 to p52 by Stat3 may represent one of the common pathways used by cancer cells to survive and escape therapy.
引用
收藏
页码:7264 / 7269
页数:6
相关论文
共 36 条
[1]  
Betts JC, 1996, MOL CELL BIOL, V16, P6363
[2]   Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers [J].
Bonizzi, G ;
Bebien, M ;
Otero, DC ;
Johnson-Vroom, KE ;
Cao, YX ;
Vu, D ;
Jegga, AG ;
Aronow, BJ ;
Ghosh, G ;
Rickert, RC ;
Karin, M .
EMBO JOURNAL, 2004, 23 (21) :4202-4210
[3]   STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[4]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[5]   Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]   Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts [J].
Ciana, P ;
Neri, A ;
Cappellini, C ;
Cavallo, F ;
Pomati, M ;
Chang, CC ;
Maiolo, AT ;
Lombardi, L .
ONCOGENE, 1997, 14 (15) :1805-1810
[8]   Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3 [J].
Cogswell, PC ;
Guttridge, DC ;
Funkhouser, WK ;
Baldwin, AS .
ONCOGENE, 2000, 19 (09) :1123-1131
[9]   CD40 regulates the processing of NF-κB2 p100 to p52 [J].
Coope, HJ ;
Atkinson, PGP ;
Huhse, B ;
Belich, M ;
Janzen, J ;
Holman, MJ ;
Klaus, GGB ;
Johnston, LH ;
Ley, SC .
EMBO JOURNAL, 2002, 21 (20) :5375-5385
[10]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635